Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010222731 | QH603.C4 C44 2008 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
This long-awaited, first comprehensive book on this topic of fundamental importance in our understanding of cancer begins with an overview of cellular junctions, before covering cell-matrix junctions, cell-cell junctions and cell-matrix and cell-cell adhesion in separate sections.
Of high interest to cell and molecular biologists, cancer researchers, oncologists, biochemists, pharmaceutists and those working in the pharmaceutical industry.
Author Notes
Susan LaFlamme is a professor in the Center for Cell Biology and Cancer Research at the Albany Medical College in Albany NY. She obtained her B.A. from Barnard College and her PhD from Columbia University in New York NY, USA. Professor LaFlamme has received many grants for her studies on integrin signaling and has published extensively in this area. She has served on review panels for the National Institutes of Health, the American Cancer Society and the American Heart Association.
Andrew Kowalczyk is an Associate Professor for Cell Biology and Dermatology at Emory School of Medicine in Atlanta GA, USA. Dr. Kowalczyk obtained his PhD at Albany Medical School in Albany NY and carried out postdoctoral studies at Northwestern University Medical School in Chicago IL, USA. He has received numerous grants and awards and has published extensively in the area of cell adhesion. He has served on review panels for the National Institutes of Health and the American Heart Association, and on several advisory committees for the Society for Investigative Dermatology.
Table of Contents
Preface | p. V |
List of Contributors | p. XIII |
Part 1 Cell-Matrix Junctions | |
1 The Ins and Outs of Integrin Signaling | p. 3 |
1.1 General Overview | p. 3 |
1.1.1 Integrin Receptors | p. 3 |
1.1.2 Functions | p. 4 |
1.2 Integrin Activation | p. 5 |
1.2.1 Definition | p. 5 |
1.2.1.1 Platelets | p. 6 |
1.2.1.2 Leukocytes | p. 6 |
1.2.2 Structural Basis of Activation | p. 6 |
1.2.2.1 Extracellular Rearrangements | p. 7 |
1.2.2.2 Transmembrane Propagation | p. 7 |
1.2.2.3 Intracellular Rearrangements | p. 8 |
1.2.2.4 Interactions at the Integrin Cytoplasmic Domains | p. 9 |
1.2.3 Regulation of Integrin Activation | p. 13 |
1.2.4 Future Research Directions | p. 16 |
References | p. 18 |
2 Integrin Signaling Through Focal Adhesion Kinase | p. 25 |
2.1 Introduction | p. 25 |
2.2 Structure of FAK | p. 26 |
2.3 Regulation of FAK Activity | p. 28 |
2.3.1 Activation of FAK | p. 28 |
2.3.2 Inhibition of FAK Activity | p. 30 |
2.4 Regulation of Cellular Functions by FAK Signaling Pathways | p. 30 |
2.4.1 Cell Adhesion and Spreading | p. 31 |
2.4.2 Cell Migration and Invasion | p. 32 |
2.4.3 Cell Survival and Proliferation | p. 36 |
2.5 Recent Analysis of FAK Functions In Vivo | p. 37 |
2.6 Conclusions | p. 39 |
Acknowledgment | p. 39 |
References | p. 39 |
3 The Paxillin Family and Tissue Remodeling | p. 47 |
3.1 Focal Adhesions and the Paxillin Superfamily | p. 47 |
3.1.1 Focal Adhesions | p. 47 |
3.1.2 The Paxillin Superfamily | p. 49 |
3.1.3 Structure of Paxillin | p. 50 |
3.1.4 Structure of Hic-5 | p. 51 |
3.2 The Paxillin Superfamily and Tissue Remodeling | p. 52 |
3.2.1 Epithelial-Mesenchymal Transformation | p. 52 |
3.2.2 Integrin-Mediated Signaling and EMT | p. 53 |
3.2.3 Paxillins [alpha] and [delta] in EMT | p. 56 |
3.2.4 Hic-5 and EMT | p. 58 |
References | p. 60 |
4 Adhesion Dynamics in Motile Cells | p. 71 |
4.1 Introduction | p. 71 |
4.2 Focal Adhesion Dynamics | p. 72 |
4.2.1 Focal Adhesion Composition | p. 73 |
4.2.2 Mechanisms of Focal Adhesion Assembly | p. 74 |
4.2.2.1 Rho GTPases | p. 75 |
4.2.2.2 Talin and Phosphoinositides | p. 75 |
4.2.3 Mechanisms of Focal Adhesion Disassembly | p. 75 |
4.2.3.1 Calpain | p. 76 |
4.2.3.2 Tyrosine Phosphorylation and Contractile Machinery | p. 76 |
4.3 Podosome and Invadopodia Dynamics | p. 76 |
4.3.1 Podosome and Invadopodia Architecture | p. 77 |
4.3.2 Molecular Mechanisms of PTA Assembly | p. 78 |
4.3.2.1 Actin Regulatory Proteins | p. 78 |
4.3.2.2 Rho GTPases | p. 79 |
4.3.2.3 Signaling Molecules | p. 79 |
4.3.3 Molecular Mechanisms of PTA Disassembly | p. 80 |
4.4 Summary | p. 80 |
Acknowledgments | p. 81 |
References | p. 81 |
5 Integrin Trafficking | p. 89 |
5.1 Introduction | p. 89 |
5.2 Historical Perspective | p. 89 |
5.3 Clathrin versus Lipid Rafts | p. 90 |
5.4 Internalization of Occupied versus Unoccupied Integrins | p. 91 |
5.5 Regulation of Integrin Trafficking | p. 92 |
5.6 The Role of Integrin Cytoplasmic Domains | p. 94 |
5.7 Integrin-Dependent Endocytosis of Microbial Pathogens | p. 95 |
5.8 Regulation of Cell Adhesion and Migration by Integrin Trafficking | p. 96 |
5.9 The Regulation of Integrin Trafficking by Cell Adhesion | p. 96 |
5.10 Integrin Trafficking and ECM Remodeling | p. 98 |
5.11 Conclusions | p. 100 |
Acknowledgments | p. 101 |
References | p. 101 |
6 Hemidesmosomes and their Components: Adhesion versus Signaling in Health and Disease | p. 109 |
6.1 Introduction | p. 109 |
6.2 The Structural Components of the Hemidesmosome | p. 110 |
6.2.1 The Plaque Proteins | p. 110 |
6.2.1.1 Plectin | p. 110 |
6.2.1.2 BP230 | p. 112 |
6.2.2 Membrane Elements | p. 112 |
6.2.2.1 [alpha]6[beta]4 Integrin | p. 112 |
6.2.2.2 BP180 | p. 114 |
6.2.2.3 CD151 | p. 115 |
6.3 Laminin-332 | p. 115 |
6.4 Hemidesmosome Assembly and Disassembly | p. 116 |
6.5 Hemidesmosomes and Disease | p. 118 |
6.5.1 Inherited Skin Diseases Involving Hemidesmosome Proteins | p. 118 |
6.5.1.1 Disease Involving [alpha]6[beta]4 Integrin | p. 118 |
6.5.1.2 Disease Involving Plectin | p. 119 |
6.5.1.3 Disease Involving BP180 | p. 119 |
6.5.1.4 Disease Involving CD151 | p. 120 |
6.5.1.5 Disease Involving Laminin-332 | p. 120 |
6.5.2 Autoimmune Diseases Associated with Hemidesmosomes | p. 121 |
6.5.2.1 BP and Related Diseases | p. 121 |
6.5.2.2 Cicatricial Pemphigoid | p. 122 |
6.5.2.3 Autoimmune Diseases Involving [alpha]6[beta]4 Integrin | p. 122 |
6.6 [alpha]6[beta]4 Integrin and Laminin-332 Expression in Cancer | p. 123 |
6.7 Signaling by the [alpha]6[beta]4 Integrin in Pathological States and Wound Healing | p. 123 |
6.8 Laminin-332, [alpha]6[beta]4 Integrin and Migration | p. 125 |
6.9 Conclusions | p. 126 |
References | p. 126 |
7 Cell Matrix Adhesion in Three Dimensions | p. 135 |
7.1 Introduction | p. 135 |
7.2 Model 3D Matrices for Investigations of Cell Behavior | p. 136 |
7.2.1 Matrigel/Reconstituted Basement Membrane (rBM) | p. 136 |
7.2.2 Collagen Gels | p. 136 |
7.2.3 Fibrin Gels | p. 138 |
7.2.4 Cell-Derived Fibronectin-Based Matrices | p. 138 |
7.2.5 Engineered 3D Matrices and Microfluidic Chambers | p. 138 |
7.3 Cell Behavior and Adhesive Structures Differ between 3D and 2D Matrices | p. 139 |
7.4 "Compliancy" or Elastic Modulus Determines Cellular Response to ECMs | p. 140 |
7.4.1 Cellular Contractility and the Response to Matrix Compliance | p. 141 |
7.4.2 Rho Regulates the Cytoskeleton and Contractility | p. 141 |
7.4.3 Rho/ROCK, Contractility, and Focal Adhesion Formation | p. 142 |
7.4.4 Focal Adhesions as Transducers of Biophysical Signals | p. 143 |
7.5 A Model for Cellular Response to 3D Matrices Varying in Compliance | p. 144 |
Acknowledgments | p. 146 |
References | p. 146 |
Part 2 Cell-Cell Junctions | |
8 Armadillo Repeat Proteins at Epithelial Adherens Junctions | p. 153 |
8.1 Introduction | p. 153 |
8.2 [beta]-Catenin | p. 156 |
8.3 Plakoglobin | p. 158 |
8.4 p120-Catenin | p. 159 |
8.5 The Role of Armadillo Repeat Proteins and AJs in Cancer | p. 163 |
8.6 Conclusions | p. 165 |
References | p. 165 |
9 Signaling To and Through The Endothelial Adherens Junction | p. 169 |
9.1 Introduction | p. 169 |
9.2 Cadherins | p. 170 |
9.2.1 VE-Cadherin Extracellular Domain | p. 173 |
9.2.2 Interaction of Cadherin Cytoplasmic Domain and Catenins | p. 174 |
9.2.2.1 VE-Cadherin Juxtamembrane Region and p120 | p. 174 |
9.2.2.2 VE-Cadherin Catenin Binding Domain | p. 176 |
9.3 Phosphorylation and Junction Assembly/Disassembly | p. 179 |
9.3.1 Tyrosine Phosphorylation of Endothelial AJ Proteins | p. 180 |
9.3.2 Serine/Threonine Phosphorylation of Endothelial AJ Proteins | p. 182 |
9.4 Small GTPases and Junction Assembly | p. 183 |
9.4.1 Rho GTPases | p. 183 |
9.4.2 Rap1 GTPase | p. 186 |
9.5 Conclusions | p. 187 |
References | p. 187 |
10 Gap Junctions: Connexin Functions and Roles in Human Disease | p. 197 |
10.1 Introduction | p. 197 |
10.2 Connexin Structure and Assembly | p. 198 |
10.3 Interactions Between Different Connexins | p. 199 |
10.4 Connexin Binding Proteins and Phosphorylation | p. 201 |
10.5 Channel Permeability and Signaling | p. 202 |
10.6 Connexins in Human Disease | p. 203 |
10.7 Role of Connexins in Vessel Inflammation and Atherosclerosis | p. 206 |
10.8 Conclusions | p. 207 |
References | p. 208 |
11 Tight Junctions in Simple and Stratified Epithelium | p. 217 |
11.1 Introduction | p. 217 |
11.2 Ultrastructure of Tight Junctions | p. 218 |
11.3 Tight Junctions and Epithelial Barrier Function | p. 219 |
11.3.1 Transmembrane Components | p. 219 |
11.3.2 Scaffolding Proteins | p. 221 |
11.3.3 Actin and Related Cytoskeleton Proteins | p. 221 |
11.4 Regulation of Tight Junction Barrier Function | p. 222 |
11.5 Tight Junctions and Epithelial Polarity | p. 222 |
11.5.1 Par3/Par6/aPKC Complex | p. 223 |
11.5.2 Crbs/Patj/Pals | p. 223 |
11.5.3 Fence Function | p. 224 |
11.6 Signaling from Tight Junctions: Coupling Junction Maturation to Transcription-Mediated Differentiation | p. 225 |
11.7 Tight Junctions in Stratifying Epithelia | p. 225 |
11.8 Tight Junctions and Disease | p. 227 |
11.9 Concluding Remarks | p. 228 |
Acknowledgments | p. 229 |
References | p. 229 |
12 Desmosomes in Development and Disease | p. 235 |
12.1 Introduction | p. 235 |
12.2 Molecular Composition of Desmosomes, Disease Associations, and Animal Models | p. 236 |
12.2.1 Desmosomal Cadherins | p. 236 |
12.2.2 Desmoplakin | p. 240 |
12.3 Plakoglobin | p. 240 |
12.4 Plakophilins | p. 242 |
12.5 Accessory Desmosomal Proteins | p. 243 |
12.6 Desmosomal Proteins in Embryonic Development | p. 243 |
12.7 Concluding Remarks | p. 244 |
Acknowledgments | p. 245 |
References | p. 245 |
13 Cadherin Trafficking and Junction Dynamics | p. 251 |
13.1 Introduction | p. 251 |
13.2 Exocytosis and Polarized Sorting of Adherens Junction Proteins | p. 252 |
13.3 Endocytosis of Adherens Junction Proteins | p. 255 |
13.4 Catenin Regulation of Cadherin Endocytosis | p. 258 |
13.5 Rho GTPase Regulation of Cadherin Endocytosis | p. 261 |
13.6 Co-Regulation of Cadherin and Receptor Tyrosine Kinase Function by Endocytosis | p. 262 |
13.7 Conclusions | p. 264 |
Acknowledgments | p. 266 |
References | p. 266 |
Part 3 Cell-Matrix and Cell-Cell Crosstalk | |
14 Crosstalk Between Cell-Cell and Cell-Matrix Adhesion | p. 273 |
14.1 Introduction | p. 273 |
14.1.1 Coordinate Regulation of Cell-Cell and Cell-Matrix Adhesion | p. 273 |
14.1.2 Crosstalk Between Integrins and Cadherins | p. 274 |
14.2 Mechanisms of Integrin-Cadherin Crosstalk | p. 275 |
14.2.1 Extracellular Proteolysis | p. 275 |
14.2.2 Cross-Regulation of Gene Expression | p. 277 |
14.2.3 Changes in Intracellular Force Generation | p. 278 |
14.2.4 Integrin-Cadherin Associations at Sites of Cell Adhesion | p. 279 |
14.2.5 Intracellular Signal Transduction Pathways | p. 281 |
14.2.5.1 FAK: An Integrin Effector that Signals to Cadherins | p. 282 |
14.2.5.2 Fer: A Tyrosine Kinase that Translocates between Cadherins and Integrins | p. 282 |
14.2.5.3 Rap1: A Central Regulator of Integrin-Cadherin Crosstalk Pathways? | p. 283 |
14.2.5.4 The Epidermis as a Model for Investigating Cadherin-Integrin Crosstalk | p. 285 |
14.3 Future Prospects | p. 286 |
Acknowledgments | p. 287 |
References | p. 287 |
Index | p. 295 |